Christina Wyatt is a Nephrology physician. OpenAlex indexes 241 publications with 6,664 citations (h-index 45).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5 East 98th Street
Box 1118 Mount Sinai Hospital Nephrology
New York, NY 10029
Telephone
212-241-4060Registry record last updated 8 Jul 2007.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20253 payments
- Novo Nordisk Health Care AGProgram year20251 payment
- Boston Scientific CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
60.2%Calcium channel blocker22.6%Amlodipine Besylate100%Part D≥20 patientsAldosterone antagonist (MRA)11.8%Spironolactone50%Eplerenone50%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
25.8%Vitamin D3 Analog25.8%Calcitriol100%Part D≥16 patientsMusculoskeletal
8.1%Xanthine oxidase inhibitor8.1%Allopurinol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2007–2017 per NIH RePORTER. The latest:
- Impact of early antiretroviral therapy on kidney disease outcomes
Icahn School of Medicine at Mount Sinai
FY2017$453,239R01DK112258 - Incidence and Implications of Subclinical Kidney Injury with Tenofovir based PrEP
Icahn School of Medicine at Mount Sinai
FY2016$494,088R01DK100272 - Incidence and Implications of Subclinical Kidney Injury with Tenofovir based PrEP
Icahn School of Medicine at Mount Sinai
FY2016$99,931R01DK100272
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population
American Journal of Kidney Diseases
2020 - The spectrum of kidney biopsy findings in HIV-infected patients in the modern era
Kidney International
2020
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”